中文|English

Current issue
2024-5-25
Vol 32, issue 5

ISSUE

2023 年4 期 第31 卷

新进展 HTML下载 PDF下载

慢性阻塞性肺疾病与冠心病共病研究进展

Research Progress on Comorbidity of Chronic Obstructive Pulmonary Disease and Coronary Heart Disease

作者:刘洪如,武冬民,李娜,王林霞,王耀勇

单位:
1.山西医科大学汾阳学院2.山西省汾阳医院呼吸与危重症医学科
Units:
1.Fenyang College of Shanxi Medical University, Fenyang 032200, China2.Department of Respiratory and Critical Care Medicine, Fenyang Hospital of Shanxi Province, Fenyang 032200, China
关键词:
慢性阻塞性肺疾病; 冠心病; 共病; 综述;
Keywords:
Chronic obstructive pulmonary disease; Coronary heart disease; Comorbidity; Review
CLC:
DOI:
10.12114/j.issn.1008-5971.2023.00.034
Funds:
山西省卫健委医学重点科研攻关专项(2020XM30);

摘要:

慢性阻塞性肺疾病(COPD)与冠心病均是严重危害人类健康的常见慢性病且二者关系密切。研究表明,COPD患者发生冠心病的风险是非COPD患者的1.24倍,而冠心病患者COPD发病率为18%~41%,与单纯COPD或单纯冠心病患者相比,COPD与冠心病共病患者预后更差。本文主要综述了COPD与冠心病共病的危险因素、发病机制、预防及治疗,旨在提高临床医生对COPD与冠心病共病的诊疗水平。

Abstract:

Chronic obstructive pulmonary disease (COPD) and coronary heart disease are common chronic diseasesthat seriously endanger human health and are closely related. Studies have shown that the risk of coronary heart disease in COPDpatients is 1.24 times than that of non-COPD patients, and the incidence of COPD in patients with coronary heart disease is 18%-41%. Compared with patients with simple COPD or simple coronary heart disease, the prognosis of patients with comorbidityof COPD and coronary heart disease is worse. This article reviews the risk factors, pathogenesis, prevention, and treatment ofcomorbidity of COPD and coronary heart disease, in order to improve the diagnosis and treatment of COPD and coronary heartdisease by clinicians.

ReferenceList: